academic article

• Comparison of outcomes for African Americans, Hispanics, and Non-Hispanic Whites in the CATIE study..  Psychiatric services (Washington, D.C.).  64:570-578. 2013
• Impact of antipsychotic medication on family burden in schizophrenia: longitudinal results of CATIE trial..  Schizophrenia research.  116:118-125. 2010
• Employment outcomes in a randomized trial of second-generation antipsychotics and perphenazine in the treatment of individuals with schizophrenia. 2008
• The effectiveness of antipsychotic medications in patients who use or avoid illicit substances: results from the CATIE study..  Schizophrenia research.  100:39-52. 2008
• Baseline neurocognitive deficits in the CATIE schizophrenia trial..  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.  31:2033-2046. 2006
• Components and correlates of family burden in schizophrenia..  Psychiatric services (Washington, D.C.).  57:1117-1125. 2006
• Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study..  Psychiatric services (Washington, D.C.).  57:1110-1116. 2006
• Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study..  The Journal of nervous and mental disease.  194:164-172. 2006
• The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development..  Schizophrenia bulletin.  29:15-31. 2003